Medicine and Dentistry
Chronic Kidney Disease
100%
Nephropathy
69%
Blood Pressure
38%
Clinical Endpoint
30%
ACE Inhibitor
30%
Finger
30%
Valsalva Maneuver
30%
Hemodialysis
30%
Kidney Cancer
30%
Albuminuria
30%
Medical Decision Making
30%
Kidney Function
30%
Photoelectric Plethysmography
30%
Hematinic
30%
Angiotensin II
30%
Renin Angiotensin Aldosterone System
17%
Health Literacy
15%
Apoplexy
14%
Pulse Rate
13%
Anemia
11%
Angiotensin Receptor Antagonist
10%
Hemodynamic
10%
Clinical Trial
10%
Endothelial Function
10%
Antihypertensive Agent
10%
Hypotension
10%
Cardiovascular System
10%
Heart Ventricle Remodeling
10%
Proteinuria
10%
Atherosclerosis
10%
Vascular Disease
10%
Plasminogen Activator Inhibitor
10%
Sodium Glucose Cotransporter 2 Inhibitor
7%
Glycemic Control
7%
Malignant Neoplasm
7%
Ideal Body Weight
7%
Patient Population
7%
Proton-Pump Inhibitor
7%
Glomerular Filtration Rate
7%
Cardiovascular Disease
7%
Anti-Inflammatory Drug
7%
Renal Failure
7%
Glucagon-Like Peptide-1 Agonist
7%
Patient with Type 2 Diabetes
7%
Cardiovascular Mortality
7%
Public Health
7%
Substitution Therapy
7%
Adverse Outcome
7%
Patient with Diabetes
7%
Hope
7%
Keyphrases
Chronic Kidney Disease
84%
Blood Pressure
38%
Clinical Endpoints
30%
Trimlines
30%
Clinical Approach
30%
Kidney Cancer
30%
Angiotensin II (Ang II)
30%
Albuminuria
30%
Pressure Effect
30%
Digit Bias
30%
End-digit Preference
30%
Angiotensin-converting Enzyme Inhibitor (ACEi)
30%
Erythropoiesis-stimulating Agents
30%
Kidney Function Decline
30%
Finger Photoplethysmography
30%
Renal Disease
20%
Hemoglobin Level
11%
Vessel Wall
10%
Blood Pressure Level
10%
Plasminogen Activator inhibitor-1 (PAI-1)
10%
Low Blood Pressure
10%
Hypertrophy
10%
Invasive Blood Pressure
10%
Clinical Trials
10%
Proteinuria
10%
Inflammation
10%
Renin-angiotensin System
10%
Angiotensin Receptor Blockers
10%
Cardiac Remodeling
10%
Antihypertensive Drugs
10%
Vascular Disease
10%
Blood Pressure Lowering
10%
Cardiac Disease
10%
Progressive Renal Disease
10%
Negative Effects
10%
Endothelial Function
10%
Cardiovascular Events
10%
Organ-specific
10%
Patient-specific Therapy
7%
Glycemic Control
7%
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i)
7%
Disability
7%
Glomerular Filtration Rate
7%
A1 Receptor
7%
Anemia
7%
Kidney Disease
7%
Cardiovascular Disease
7%
Clinical High Risk
7%
Highly Effective
7%
World Population
7%
Nursing and Health Professions
Chronic Kidney Failure
69%
Diastolic Blood Pressure
53%
Systolic Blood Pressure
38%
Faculty Practice
30%
Antianemic Agent
30%
Kidney Cancer
30%
Nursing Staff
30%
Non Invasive Blood Pressure Monitor
30%
Blood Pressure Cuff
30%
Medical Decision Making
30%
Medical Device
30%
Kidney Disease
30%
Blood Pressure
30%
Clinical Evaluation
30%
Blood Pressure Measurement
23%
Hospital
23%
Ambulatory Care
15%
Health Literacy
15%
Blood Pressure Monitoring
15%
Hemoglobin Blood Level
11%
Anemia
11%
Body Mass
7%
Physician
7%
Patient Population
7%
Primary Medical Care
7%
Health Center
7%
Malignant Neoplasm
7%
Mercury Sphygmomanometer
7%